 |
|
Home | Research Analysts’ Downgrades for January, 10th (ANGO, BMRN, BP, CDE, CUDA, DEST, EBF, ESYJY, JNJ, LLY) |
 |
Research Analysts’ Downgrades for January, 10th (ANGO, BMRN, BP, CDE, CUDA, DEST, EBF, ESYJY, JNJ, LLY)
|
 |
- January 10, 2014
-
Research Analysts’ downgrades for Friday, January 10th: AngioDynamics (NASDAQ:ANGO) was downgraded by analysts at Jefferson Research from a buy rating to a hold rating. BioMarin Pharmaceutical (NASDAQ:BMRN) was downgraded by analysts at Barclays to an equal weight rating. BP PLC (NYSE:BP) was downgraded by analysts at BNP Paribas from an outperform rating to a neutral […]This article (Research Analysts’ Downgrades for January, 10th (ANGO, BMRN, BP, CDE, CUDA, DEST, EBF, ESYJY, JNJ, LLY)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2014/01/10/research-analysts-downgrades-for-january-10th-ango-bmrn-bp-cde-cuda-dest-ebf-esyjy-jnj-lly/
- Investment Analysts’ New Coverage for January, 10th (ASGN, BIOA, BJRI, CACH, CLSN, CQH, CQP, DRI, ECL, EOX)
- Analysts’ Price Target Changes for January, 10th (CCA, CDV, CNQ, DDD, ECOM, GS, ICPT, INCY, ITMN, JAH)
- Rising Aussie house prices 'bad'
- More jobless give up on finding work
|
 |
|
 |
|
 |
